Unknown

Dataset Information

0

Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty.


ABSTRACT: Prescription patterns for acne/rosacea medications have not been described in the Medicare population, and comparisons across specialties are lacking.To describe the medications used for treating acne/rosacea in the Medicare population and evaluate differences in costs between specialties.A cross-sectional study was performed of the 2008 and 2010 Centers for Medicare and Medicaid Services Prescription Drug Profiles, which contains 100% of Medicare part D claims.Topical antibiotics accounted for 63% of all prescriptions. Patients ?65 years utilized more oral tetracycline-class antibiotics and less topical retinoids. Specialists prescribed brand name drugs for the most common topical retinoids and most common topical antibiotics more frequently than family medicine/internal medicine (FM/IM) physicians by 6%-7%. Topical retinoids prescribed by specialists were, on average, $18-$20 more in total cost and $2-$3 more in patient cost than the same types of prescriptions from FM/IM physicians per 30-day supply. Specialists (60%) and IM physicians (56%) prescribed over twice the rate of branded doxycycline than FM doctors did (27%). The total and patient costs for tetracycline-class antibiotics were higher from specialists ($18 and $4 more, respectively) and IM physicians ($3 and $1 more, respectively) than they were from FM physicians.The data might contain rare prescriptions used for conditions other than acne/rosacea, and suppression algorithms might underestimate the number of specialist brand name prescriptions.Costs of prescriptions for acne/rosacea from specialists are higher than those from primary care physicians and could be reduced by choosing generic and less expensive options.

SUBMITTER: Zhang M 

PROVIDER: S-EPMC5557700 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty.

Zhang Myron M   Silverberg Jonathan I JI   Kaffenberger Benjamin H BH  

Journal of the American Academy of Dermatology 20170623 3


<h4>Background</h4>Prescription patterns for acne/rosacea medications have not been described in the Medicare population, and comparisons across specialties are lacking.<h4>Objective</h4>To describe the medications used for treating acne/rosacea in the Medicare population and evaluate differences in costs between specialties.<h4>Methods</h4>A cross-sectional study was performed of the 2008 and 2010 Centers for Medicare and Medicaid Services Prescription Drug Profiles, which contains 100% of Medi  ...[more]

Similar Datasets

| S-EPMC6453570 | biostudies-literature
| S-EPMC5732892 | biostudies-literature
| S-EPMC5071277 | biostudies-literature
| S-EPMC5907557 | biostudies-literature
| S-EPMC6557654 | biostudies-literature
| S-EPMC2742307 | biostudies-other
| S-EPMC3725527 | biostudies-literature
| S-EPMC6468129 | biostudies-literature
| S-EPMC1824717 | biostudies-literature
| S-EPMC8697132 | biostudies-literature